--- title: Tempus AI slug: tempus-ai-530d4 url: /detay/tempus-ai-530d4 type: article language: English entity: primary: Tempus AI type: article categories: - name: Science And Technology slug: bilim url: /kategori/bilim - name: Engineering slug: muhendislik url: /kategori/muhendislik - name: Technology And Innovation slug: teknoloji url: /kategori/teknoloji tags: - Tempus AI author: Ömer Said Aydın created_at: 2025-10-25T15:35:14.589699+03:00 updated_at: 2025-10-28T16:52:24.462020+03:00 image: https://cdn.t3pedia.org/media/uploads/2025/10/25/SqrD0TwtG4YZhRbXFAbTxYfIN4GehhSd.jpg --- # Tempus AI ## KURE Information Cards ![tempuslabs_logo.jpg](https://cdn.t3pedia.org/media/uploads/2025/10/25/nvhr3YIvcJbOKY1Fe915V5YtiBdRpplW.jpg) *Tempus AI* | Field | Value | |-------|-------| | Website(s) | https://www.tempus.com | | Founded(Text) | 2015 | | Headquarters | Chicago, Illinois, United States | ## Article Content **Tempus AI** is a healthcare technology company developing **artificial intelligence–driven precision medicine applications**. By integrating clinical and molecular data into a comprehensive knowledge platform, Tempus enables physicians to make **real-time, data-informed decisions**. Its core mission is to ensure that every patient benefits from the experiences and data of those who came before, advancing personalized and targeted treatment strategies. ### **History** Tempus was founded in **2015** by **Eric Lefkofsky** after his wife, Elizabeth Lefkofsky, was diagnosed with breast cancer. Motivated to integrate [AI](/en/detay/artificial-intelligence-in-health-ee8e4/llms.txt) and technology into cancer care, Lefkofsky established the company with **Ryan Fukushima** as its first employee. Initially focused on [oncology](/en/detay/teknofest-oncology-3t-competition-440d0/llms.txt), Tempus has since expanded into **neuropsychiatry, cardiology, radiology,** and **infectious diseases**. The company is headquartered in **Chicago, Illinois**. ### **Technological Platforms** Tempus operates within a framework it calls **“Precision Medicine 2.0”**—an AI-based healthcare ecosystem designed to accelerate clinical decision-making and research. Its primary platforms include: - **Tempus Hub:** A digital system allowing healthcare professionals to manage genetic and clinical tests, access results, and build patient cohorts. - **Tempus One:** A generative AI–powered clinical assistant integrated with electronic health records (EHRs). - **Tempus Lens:** An AI analytics engine linking real-world data and organoid models to identify biomarkers and validate therapeutic targets. - **Tempus Pixel:** An AI imaging platform used in radiology for diseases such as lung, breast, cardiac, and prostate conditions; includes automated lesion segmentation and longitudinal tracking. - **Tempus Next:** An AI-powered care pathway system that identifies treatment gaps and guides patients to appropriate diagnosis and therapy. - **Tempus Merlin:** An algorithmic assay combining gene expression and clinicopathological data to predict recurrence and biopsy risk in melanoma patients. ### **Clinical and Research Applications** Tempus collaborates with over **3,000 healthcare institutions**, maintaining **more than 8 million de-identified patient records** and over **600 direct data integrations**. Its AI models support diagnosis, treatment, and research in **oncology**, **neurology**, **cardiology**, and **psychiatry**. The company’s **Next-Generation Sequencing (NGS)** laboratories are **CAP-accredited** and **CLIA-certified**, enabling a wide range of genomic tests, including: - **Tempus xT:** 648-gene targeted sequencing panel - **Tempus xE:** Whole exome sequencing - **Tempus xR:** Transcriptome analysis - **Tempus xF/xF+:** Liquid biopsy panels Tempus also provides **multi-omic technologies**, including methylation profiling, single-cell sequencing, proteomics, and spatial transcriptomics. The **Tempus | M** laboratory uses **patient-derived tumor organoids** to study the effects of genomic alterations on treatment response and immune evasion, supporting biomarker discovery and drug sensitivity analysis. ### **Partnerships** Tempus maintains partnerships with over **200 biopharmaceutical companies** and leading U.S. healthcare institutions. Collaborations with **AstraZeneca, Pfizer, Genmab, BioNTech, GSK, Bristol Myers Squibb, Bayer,** and **Takeda** focus on biomarker-driven therapies, clinical trial design, and real-world data analytics. In cardiovascular medicine, Tempus developed **FDA-approved algorithms** such as **ECG-AF** and **ECG-Low EF**, which detect atrial fibrillation and low ejection fraction risk through electrocardiogram data analysis. In neuropsychiatry, the **Tempus nP pharmacogenomic test** personalizes drug selection and dosing for conditions such as depression, anxiety, and ADHD. The **TIME Trial® Program** accelerates patient access to biomarker-driven clinical trials by using pre-approved IRB protocols and standardized contracting frameworks, reducing trial initiation time from months to weeks. ### **Corporate Structure and Culture** Tempus’s leadership team includes **Eric Lefkofsky (CEO)**, **Ryan Fukushima (COO)**, and **Kate Sasser (Chief Scientific Officer)**. The company’s cultural values are summarized as **Time, Patients, Perspective, Learning, Respect,** and **Saving Lives**. In **2024**, Tempus was recognized by *Built In* as one of the **“Top Places to Work.”** ### **Scientific Vision** [Tempus AI](/en/detay/tempus-ai-2802d/llms.txt) combines **large-scale clinical and molecular datasets** with advanced AI algorithms to expand the practical applications of **precision medicine**. Its integrated, data-centric infrastructure enhances diagnostic accuracy, treatment efficacy, and clinical research efficiency—advancing the broader transformation of healthcare into a predictive, personalized, and learning-based system. ## Academic Sources and References 1. Tempus. “About Us: Culture.” Official Website. Accessed October 24, 2025. https://www.tempus.com/about-us/culture/.Tempus. “About Us: Our History.” Official Website. Accessed October 24, 2025. https://www.tempus.com/about-us/our-history/.Tempus. “About Us: Our Team.” Official Website. Accessed October 24, 2025. https://www.tempus.com/about-us/our-team/.Tempus. “About Us: Tempus Tech.” Official Website. Accessed October 24, 2025. https://www.tempus.com/about-us/tempus-tech/.Tempus. “Cardiology.” Official Website. Accessed October 24, 2025. https://www.tempus.com/cardiology/.Tempus. “Dermatology.” Official Website. Accessed October 24, 2025. https://www.tempus.com/dermatology/.Tempus. “Life Sciences.” Official Website. Accessed October 24, 2025. https://www.tempus.com/life-sciences/.Tempus. “Neurology & Psychiatry.” Official Website. Accessed October 24, 2025. https://www.tempus.com/neurology-psychiatry/.Tempus. “Oncology.” Official Website. Accessed October 24, 2025. https://www.tempus.com/oncology/.Tempus. “Radiology.” Official Website. Accessed October 24, 2025. https://www.tempus.com/radiology/.Tempus. “Research.” Official Website. Accessed October 24, 2025. https://www.tempus.com/research/.Tempus Labs. “About.” LinkedIn. Accessed October 24, 2025. https://www.linkedin.com/company/tempusai/.